We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PTC
PTC
$13.7B
| $26.7M | 0.35% |
738,227
-399,195
| -35% | -$13.8M |
|
77
Devon Energy
DVN
$51.9B
| $26.4M | 0.34% |
437,391
+145,380
| +50% | +$8.86M |
|
|
MJN
78
DELISTED
Mead Johnson Nutrition Company
MJN
| $26.1M | 0.34% |
259,322
+52,879
| +26% | +$5.33M |
|
79
Apple
AAPL
$4.89T
| $25.9M | 0.34% |
831,408
-389,348
| -32% | -$11.8M |
|
|
VIAB
80
DELISTED
Viacom Inc. Class B
VIAB
| $25.4M | 0.33% |
372,336
+351,351
| +1,674% | +$24.3M |
|
81
Sysco
SYY
$39.7B
| $25.4M | 0.33% |
672,574
+648,373
| +2,679% | +$25.5M |
|
82
Medtronic
MDT
$107B
| $25.3M | 0.33% |
324,405
+237,405
| +273% | +$18M |
|
83
DexCom
DXCM
$27.6B
| $25.3M | 0.33% |
1,621,380
+774,316
| +91% | +$11.7M |
|
|
84
Micron Technology
MU
$1.04T
| $24.8M | 0.32% |
912,398
-2,241,723
| -71% | -$67M |
|
|
CYT
85
DELISTED
CYTEC INDS INC
CYT
| $24.3M | 0.32% |
450,466
+204,085
| +83% | +$10.2M |
|
86
Advance Auto Parts
AAP
$3.37B
| $24.1M | 0.31% |
161,247
-137,435
| -46% | -$21.2M |
|
|
ENDP
87
DELISTED
Endo International plc
ENDP
| $23.8M | 0.31% |
265,031
+218,412
| +469% | +$18.3M |
|
|
BERY
88
DELISTED
Berry Global Group, Inc.
BERY
| $23.7M | 0.31% |
+713,004
| New | +$22.4M |
|
|
TWC
89
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $23.7M | 0.31% |
157,828
+117,523
| +292% | +$17.5M |
|
90
Minerals Technologies
MTX
$2.31B
| $23.5M | 0.31% |
321,128
+253,112
| +372% | +$17.2M |
|
91
O'Reilly Automotive
ORLY
$72.4B
| $23.5M | 0.31% |
1,627,755
-598,890
| -27% | -$8.05M |
|
|
92
HP
HPQ
$23.5B
| $22.7M | 0.3% |
1,601,074
-3,961,398
| -71% | -$65.4M |
|
93
TransDigm Group
TDG
$69.2B
| $22.5M | 0.29% |
+102,685
| New | +$21.6M |
|
|
RHT
94
DELISTED
Red Hat Inc
RHT
| $22.4M | 0.29% |
295,121
+271,153
| +1,131% | +$18.4M |
|
|
P
95
DELISTED
Pandora Media Inc
P
| $22.3M | 0.29% |
1,374,205
+1,227,374
| +836% | +$19.6M |
|
96
Eastman Chemical
EMN
$7.8B
| $22.1M | 0.29% |
+318,408
| New | +$23M |
|
97
Avient
AVNT
$3.45B
| $22M | 0.29% |
589,939
+272,008
| +86% | +$10.3M |
|
|
FCS
98
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $21.9M | 0.28% |
+1,202,885
| New | +$20.5M |
|
99
Align Technology
ALGN
$12B
| $21.6M | 0.28% |
400,813
-40,192
| -9% | -$2.29M |
|
100
FedEx
FDX
$74.5B
| $21.5M | 0.28% |
130,140
-315,936
| -71% | -$54.9M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.